Literature DB >> 15693009

ASsessment in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis.

Désirée van der Heijde1, Maxime Dougados, John Davis, Michael H Weisman, Walter Maksymowych, Jürgen Braun, David S Hallegua, Jane Bruckel.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15693009     DOI： 10.1002/art.20790

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  28 in total

1.  ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Authors:  J Zochling; D van der Heijde; R Burgos-Vargas; E Collantes; J C Davis; B Dijkmans; M Dougados; P Géher; R D Inman; M A Khan; T K Kvien; M Leirisalo-Repo; I Olivieri; K Pavelka; J Sieper; G Stucki; R D Sturrock; S van der Linden; D Wendling; H Böhm; B J van Royen; J Braun
Journal:  Ann Rheum Dis       Date:  2005-08-26       Impact factor: 19.103

2.  MRI outcomes in AS patients after two years of etanercept therapy.

Authors:  Christopher Ritchlin; Walter Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

Review 3.  Relationship between diet and ankylosing spondylitis: A systematic review.

Authors:  Tatiana V Macfarlane; Hadeel M Abbood; Ejaz Pathan; Katy Gordon; Juliane Hinz; Gary J Macfarlane
Journal:  Eur J Rheumatol       Date:  2017-10-25

4.  Possible predictors for relapse from etanercept discontinuation in ankylosing spondylitis patients in remission: a three years' following-up study.

Authors:  Minjing Zhao; Pingping Zhang; Linkai Fang; Zhongxing Luo; Jieruo Gu; Zhiming Lin
Journal:  Clin Rheumatol       Date:  2017-08-07       Impact factor: 2.980

Review 5.  Biomarkers in spondyloarthritis.

Authors:  Kyoung-Sun Na; Tae-Hwan Kim; Robert D Inman
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

Review 6.  [Outcome parameters in ankylosing spondylitis].

Authors:  H Haibel; M Rudwaleit; J Sieper
Journal:  Z Rheumatol       Date:  2006-03       Impact factor: 1.372

Review 7.  Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology.

Authors:  Susanne Juhl Pedersen; Walter P Maksymowych
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

8.  Digital tomosynthesis as a new diagnostic tool for evaluation of spine damage in patients with ankylosing spondylitis.

Authors:  Young Bin Joo; Tae-Hwan Kim; Jina Park; Kyung Bin Joo; Yoonah Song; Seunghun Lee
Journal:  Rheumatol Int       Date:  2016-12-08       Impact factor: 2.631

9.  Assessment of therapeutic response in ankylosing spondylitis patients undergoing anti-tumour necrosis factor therapy by whole-body magnetic resonance imaging.

Authors:  Martina Karpitschka; Patrizia Godau-Kellner; Herbert Kellner; Annie Horng; Daniel Theisen; Christian Glaser; Bernhard Brandlhuber; Maximilian Reiser; Sabine Weckbach
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

10.  Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing Spondylitis Global score (BASG).

Authors:  Yasser El Miedany; Sally Youssef; Annie Mehanna; Naglaa Shebrya; Sherif Abu Gamra; Maha El Gaafary
Journal:  Clin Rheumatol       Date:  2008-01-05       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.